Richard M. Altieri Net Worth

The estimated Net Worth of Richard M. Altieri is at least $4.46 Million dollars as of 24 January 2018. Richard Altieri owns over 152,330 units of Oxford Immunotec Global PLC stock worth over $4,463,200 and over the last 11 years Richard sold OXFD stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Richard Altieri OXFD stock SEC Form 4 insiders trading

Richard has made over 1 trades of the Oxford Immunotec Global PLC stock since 2018, according to the Form 4 filled with the SEC. Most recently Richard exercised 152,330 units of OXFD stock worth $27,419 on 24 January 2018.

The largest trade Richard's ever made was exercising 152,330 units of Oxford Immunotec Global PLC stock on 24 January 2018 worth over $27,419. On average, Richard trades about 13,848 units every 0 days since 2014. As of 24 January 2018 Richard still owns at least 202,965 units of Oxford Immunotec Global PLC stock.

You can see the complete history of Richard Altieri stock trades at the bottom of the page.

What's Richard Altieri's mailing address?

Richard's mailing address filed with the SEC is C/O OXFORD IMMUNOTEC GLOBAL PLC, 94C INNOVATION DRIVE, ABINGDON, OXFORDSHIRE, X0, OX14 4RZ.

Insiders trading at Oxford Immunotec Global PLC

Over the last 11 years, insiders at Oxford Immunotec Global PLC have traded over $13,598,906 worth of Oxford Immunotec Global PLC stock and bought 47,600 units worth $549,576 . The most active insiders traders include James R Tobin, Peter Wrighton Smith, and Ronald Asbury Andrews. On average, Oxford Immunotec Global PLC executives and independent directors trade stock every 36 days with the average trade being worth of $536,006. The most recent stock trade was executed by Patrick J Balthrop on 20 May 2020, trading 4,000 units of OXFD stock currently worth $49,920.

What does Oxford Immunotec Global PLC do?

Complete history of Richard Altieri stock trades at Oxford Immunotec Global PLC

Oxford Immunotec Global PLC executives and stock owners

Oxford Immunotec Global PLC executives and other stock owners filed with the SEC include:

• Peter Wrighton-Smith,
  Chief Executive Officer, Director
• Matthew McLaughlin,
  Chief Financial Officer
• Richard Sandberg,
  Independent Director
• Patrick Balthrop,
  Independent Chairman of the Board
• Herman Rosenman,
  Independent Director
• James Tobin,
  Independent Director
• Patricia Randall,
  Independent Director
• Andrew Walton,
  Independent Director
• Mark Klausner,
  Independent Director
• Ronald Andrews,
  Independent Director
• Janet Kidd,
  General Counsel, Company Secretary
• Herm Rosenman,
  
• Richard M. Altieri,
  Chief Financial Officer
• Peter Edwardson,
  Chief Operations Officer
• Stephen L Spotts,
  Director
• Jeff R. Schroeder,
  Chief Commercial Officer
• Richard Wenstrup,
  Chief Medical Officer
• Stefan C Linn,
  Chief Operating Officer
• Elizabeth M Keiley,
  VP & General Counsel
• Lifesciences I, L.P.Clarus ...,
  
• Leaf Ventures Ii, L.P.New L...,